InvestorsHub Logo
Followers 21
Posts 635
Boards Moderated 0
Alias Born 11/08/2018

Re: Whalatane post# 324884

Friday, 02/12/2021 4:04:32 AM

Friday, February 12, 2021 4:04:32 AM

Post# of 425749
Amarin PR- what PR??—-What PR practice is advising??/ who is the director at Amarin in charge of PR- who or what is the driver of PR strategy ???

Indeed do they actually have a strategy ?????

It is IMO a most telling factor as to either the BOD being totally off point - or the only other explanation is that not doing so is part of a developing BO process

Amarin -given its size as a company /turnover / advertising expenditure -and that it has a product that requires significant world wide market development does not have a leading edge PR director on the Board / nor seemingly an advising leading edge PR practice directing and driving a PR strategy

We see this in so many ways - shocking weak inconsistent untimely information that misses the mark has no bang to it - they fail to take on issues and fight the corner - compare Nissan and the Cleveland clinic ....just for one as to impact

Look what Captain Beer can produce by comparison or HK / Pharmadude as to talking point science on the subject


Of all things PR/ advertising is the future life blood of Vascepa - is it that another big pharma PR team is soon going to be taking this on and will develop in their own way ?????- or is the Amarin Board is just well ... so stupid .....that they think they can reinvent themselves from accountants to advertising PR gurus

What is going on presently is frankly laughable - bordering on downright hopeless - it is pathetic

New poll RAF ... shareholders view of Amarins PR strategy - score 0 to 10
I give them a generous 1
Alm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News